Vertex Pharmaceuticals (Mexico) Widgets and Gadgets
| VRTX Stock | MXN 8,150 42.60 0.53% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- VRTX Vertex Pharmaceuticals
- VRTX 8150.0 42.6
- Low 8150.0
- High 8150.0
- Alpha -0.14
- Beta 0.0986
- Return On Equity 0.28
- Return On Asset 0.17
- Profit Margin 0.37 %
- Operating Margin 0.49 %
- Current Valuation 1.41 T
- Shares Outstanding 257.09 M
- Shares Owned By Insiders 0.20 %
- Shares Owned By Institutions 96.96 %
- Price To Earning 17.50 X
- Price To Book 6.07 X
- Price To Sales 180.70 X
- Revenue 8.93 B
- Gross Profit 7.55 B
- EBITDA 4.29 B
- Net Income 3.32 B
- Cash And Equivalents 6.71 B
- Cash Per Share 25.86 X
- Total Debt 893.85 M
- Debt To Equity 0.1 %
- Current Ratio 4.61 X
- Book Value Per Share 54.13 X
- Cash Flow From Operations 2.64 B
- Earnings Per Share 238.31 X
- Price To Earnings To Growth 0.41 X
- Number Of Employees 4.8 K
- Beta 0.46
- Market Capitalization 1.46 T
- Total Asset 18.15 B
- Net Asset 18.15 B
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.01
- Day Median Price 8150.0
- Day Typical Price 8150.0
- Price Action Indicator 21.3
- Period Momentum Indicator 42.6
Market Snapshot Widget Example
DAX Index Germany | 19,849 0.18 | |
Taiwan Weighted Taiwan | 23,220 0.43 | |
PSI 20 Stock Portugal | 6,326 0.32 | |
CROBEX Croatia | 3,204 0.17 | |
Budapest SE Hungary | 79,493 0.95 | |
IDX 30 Jakarta Indonesia | 424.36 0.55 | |
ISEQ 20 Price Ireland | 1,631 0.42 | |
NYSE Comp USA | 19,341 0.70 | |
Tel Aviv 35 Israel | 2,394 0.36 | |
Coreshares Index Tracker South Afric | 1,128 1.26 | |
IPC MEXICO Mexico | 49,317 0.59 | |
KL Technology Malaysia | 64.10 0.12 | |
IBEX 35 Index Spain | 11,474 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,607 0.50 | |
SPASX Dividend Opportunities Australia | 1,660 0.16 | |
HNX 30 Vietnam | 481.50 0.25 | |
Bucharest BET-NG Romania | 1,214 0.52 | |
AMS Small Cap Netherlands | 1,248 0.89 | |
Oslo Exchange Mutual Norway | 1,367 0.54 | |
BEL Small Belgium | 8,217 1.09 | |
Basic Materials Brazil | 5,571 0.52 | |
Swiss Leader Price Switzerland | 1,900 0.84 | |
Fondo Mutuo ETF Chile | 1,388 0.27 | |
Athens General Comp Greece | 1,449 0.25 | |
Stock Exchange Of Thailand | 1,401 0.44 | |
PX Prague Stock Czech Repub | 1,762 0.41 | |
THE PHILIPPINE STOCK Philippines | 6,535 2.01 | |
WIG 30 Poland | 2,814 0.13 | |
BIST Electricity Turkey | 501.17 0.63 |
Investing Ideas
In addition to having Vertex Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Vertex Pharmaceuticals
Compare Vertex Pharmaceuticals To Peers
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.